Vitrolife AB
SWB:VTFN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vitrolife AB
SWB:VTFN
|
SE |
|
Japfa Ltd
SGX:UD2
|
SG |
|
A
|
Ageas SA
MIL:AGS
|
BE |
|
T
|
Thor Mining PLC
OTC:THORF
|
UK |
|
Brooks Macdonald Group PLC
LSE:BRK
|
UK |
|
L
|
Lion Posim Bhd
KLSE:POS
|
MY |
|
A
|
Ageas SA
OTC:AGESY
|
BE |
|
I
|
Israel Petrochemical Enterprises Ltd
TASE:PTCH
|
IL |
Wall Street
Price Targets
VTFN Price Targets Summary
Vitrolife AB
According to Wall Street analysts, the average 1-year price target for
VTFN
is 15.213 EUR
with a low forecast of 9.415 EUR and a high forecast of 21.043 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VTFN's stock price target?
Price Target
15.213
EUR
According to Wall Street analysts, the average 1-year price target for
VTFN
is 15.213 EUR
with a low forecast of 9.415 EUR and a high forecast of 21.043 EUR.
What is Vitrolife AB's Revenue forecast?
Projected CAGR
6%
For the last 14 years the
compound annual growth rate for
Vitrolife AB's revenue is
18%.
The projected
CAGR
for the next 3 years is
6%.
What is Vitrolife AB's Operating Income forecast?
Projected CAGR
20%
For the last 14 years the
compound annual growth rate for
Vitrolife AB's operating income is
21%.
The projected
CAGR
for the next 3 years is
20%.
